Circulating activated protein C levels are not increased in septic patients treated with recombinant human soluble thrombomodulin (Q57067780)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

title

Circulating activated protein C levels are not increased in septic patients treated with recombinant human soluble thrombomodulin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

author name string

Takuro Arishima

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Tomotsugu Yasuda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Nozomi Yashima

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Hiroaki Furubeppu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Chinatsu Kamikokuryo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Takahiro Futatsuki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Yutaro Madokoro

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Shotaro Miyamoto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Tomohiro Eguchi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Hiroyuki Haraura

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Ikuro Maruyama

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Yasuyuki Kakihana

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

language of work or name

English

0 references

publication date

28 September 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

issue

1

0 references

page(s)

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

25 April 2020

copyright license

start time

28 September 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Pharmacokinetics of Standard- and Reduced-Dose Recombinant Human Soluble Thrombomodulin in Patients with Septic Disseminated Intravascular Coagulation during Continuous Hemodiafiltration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6161343

Pharmacokinetics of recombinant human soluble thrombomodulin in disseminated intravascular coagulation patients with acute renal dysfunction

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6161343

Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6161343

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6161343

Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6161343

Thrombomodulin as an intravascular safeguard against inflammatory and thrombotic diseases

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6161343

A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6161343

Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6161343

Drotrecogin alfa (activated) in adults with septic shock.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6161343

Monitoring of plasma levels of activated protein C using a clinically applicable oligonucleotide-based enzyme capture assay

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6161343

Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6161343

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6161343

A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6161343

Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6161343

Efficacy and safety of recombinant human activated protein C for severe sepsis

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6161343

The regulation of natural anticoagulant pathways.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6161343

Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6161343

Phase I study of a novel recombinant human soluble thrombomodulin, ART-123

30 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30275773

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30275773

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacokinetics and pharmacodynamics of recombinant soluble thrombomodulin in disseminated intravascular coagulation patients with renal impairment

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30275773

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/S12959-018-0178-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

25 April 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30275773%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

PubMed publication ID

30275773

1 reference